These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. COVID-19-Associated mucormycosis: Case series from a tertiary care hospital in South India. Rashbi K S; Ali TMF; P N D; C K S; Payyappilly RJ Access Microbiol; 2022 Aug; 4(6):acmi000360. PubMed ID: 36004359 [TBL] [Abstract][Full Text] [Related]
43. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review. Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911 [TBL] [Abstract][Full Text] [Related]
44. COVID-19-associated-mucormycosis: possible role of free iron uptake and immunosuppression. Tabassum T; Araf Y; Moin AT; Rahaman TI; Hosen MJ Mol Biol Rep; 2022 Jan; 49(1):747-754. PubMed ID: 34709573 [TBL] [Abstract][Full Text] [Related]
45. As the virus sowed, the fungus reaped! A comparative analysis of the clinico-epidemiological characteristics of rhino-orbital mucormycosis before and during COVID-19 pandemic. Muraleedharan M; Panda NK; Angrish P; Arora K; Patro SK; Bansal S; Chakrabarti A; Rudramurthy SM; Bakshi J; Mohindra S; Gupta R; Virk RS; Verma RK; Ramavat AS; Nayak G Mycoses; 2022 May; 65(5):567-576. PubMed ID: 35289000 [TBL] [Abstract][Full Text] [Related]
46. Newer Horizon of Mesenchymal Stem Cell-Based Therapy in the Management of SARS-CoV-2-Associated Mucormycosis: A Safe Hope for Future Medicine. Raghav A; Ali SG; Jeong GB; Gautam KA; Banday S; Mateen QN; Tripathi P; Giri R; Agarwal S; Singh M; Khan HM Front Microbiol; 2021; 12():738983. PubMed ID: 34707590 [TBL] [Abstract][Full Text] [Related]
47. COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management. Yasmin F; Najeeb H; Naeem A; Dapke K; Phadke R; Asghar MS; Shah SMI; De Berardis D; Ullah I Diseases; 2021 Sep; 9(4):. PubMed ID: 34698143 [TBL] [Abstract][Full Text] [Related]
48. Mucormycosis and COVID-19 an epidemic in a pandemic? Banerjee I; Robinson J; Asim M; Sathian B; Banerjee I Nepal J Epidemiol; 2021 Jun; 11(2):1034-1039. PubMed ID: 34290893 [TBL] [Abstract][Full Text] [Related]
49. Resolving the equation between mucormycosis and COVID-19 disease. Pasrija R; Naime M Mol Biol Rep; 2022 Apr; 49(4):3349-3356. PubMed ID: 35064406 [TBL] [Abstract][Full Text] [Related]
50. Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital. Alloush TK; Mansour O; Alloush AT; Roushdy T; Hamid E; El-Shamy M; Shokri HM Neurol Sci; 2022 Feb; 43(2):799-809. PubMed ID: 34787754 [TBL] [Abstract][Full Text] [Related]
52. Covid-19 and mucormycosis (Black Fungus): An epidemic within the pandemic. Gambhir RS; Aggarwal A; Bhardwaj A; Kaur A; Sohi RK; Mehta S Rocz Panstw Zakl Hig; 2021; 72(3):239-244. PubMed ID: 34553877 [TBL] [Abstract][Full Text] [Related]
53. Mucormycosis - The deadly fungus - A case report with dental perspective. Chakraborty R; Pandya D; Dausage P; Chawla AK J Family Med Prim Care; 2022 Apr; 11(4):1532-1535. PubMed ID: 35516676 [TBL] [Abstract][Full Text] [Related]
54. [COVID-19 associated mucormycosis. A case in Argentina]. Aparicio M; Tuculet B; Rivolier MG; Forte A; Vila A Medicina (B Aires); 2022; 82(2):304-307. PubMed ID: 35417397 [TBL] [Abstract][Full Text] [Related]
55. Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. Ibrahim AS; Spellberg B; Edwards J Curr Opin Infect Dis; 2008 Dec; 21(6):620-5. PubMed ID: 18978530 [TBL] [Abstract][Full Text] [Related]
56. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India. Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032 [TBL] [Abstract][Full Text] [Related]
57. Management of coronavirus disease (Covid-19) associated mucormycosis with palatal ulcer, dental pain and anterior maxillary teeth mobility- A clinical dilemma of Covid 19 pandemic in India. Ahmad A; Singh A; Anand S; Megha V; Maharaj A J Family Med Prim Care; 2022 Apr; 11(4):1539-1541. PubMed ID: 35516697 [TBL] [Abstract][Full Text] [Related]
58. Clinical and microbiological features and outcomes of mucormycosis in critically ill patients. Rothe K; Braitsch K; Okrojek R; Heim M; Rasch S; Verbeek M; Schmid RM; Busch DH; Lahmer T Int J Infect Dis; 2021 Aug; 109():142-147. PubMed ID: 34229089 [TBL] [Abstract][Full Text] [Related]
59. Mucormycosis: New Developments into a Persistently Devastating Infection. Danion F; Aguilar C; Catherinot E; Alanio A; DeWolf S; Lortholary O; Lanternier F Semin Respir Crit Care Med; 2015 Oct; 36(5):692-705. PubMed ID: 26398536 [TBL] [Abstract][Full Text] [Related]
60. Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs. Roilides E; Antachopoulos C; Simitsopoulou M Mycoses; 2014 Dec; 57 Suppl 3():40-7. PubMed ID: 25175306 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]